Founded in 2012 and headquartered in Portugal, FairJourney is a Contract Research Organization that supports pharmaceutical and biotech companies in developing antibody-based therapies. FairJourney provides services for the discovery, engineering, production, and characterization of antibodies. FairJourney has worked with over 250 clients to develop more than 4,000 unique screening libraries for identifying antibodies.
Thematic
FairJourney is set to benefit from structural tailwinds driving growth in the market for antibody discovery. This includes higher R&D spending by the pharmaceutical industry, increased outsourcing to specialized innovation partners, the established track record of antibody-based therapies, and a favorable regulatory landscape.
Business building
Partners Group is working with founder António Parada, who remains a significant shareholder, and the management team on a value creation plan for FairJourney that will expand its technology and capabilities through organic and inorganic investment to unlock faster, more effective drug development for the company’s partners.
